Robert Lenk
Förmögenhet: 32 435 $ per 2026-05-31
Förmögenhet: 32 435 $ per 2026-05-31
Robert P.
Lenk was the founder of The Liposome Co., Inc., founded in 1981, and Argus Pharmaceuticals, Inc., founded in 1989, where the title held was Vice President-Research & Development.
Current jobs include Director at POP Biotechnologies, Inc., Partner at Houston Partners Private Equity Group LLC, and President at Lenk Pharmaceuticals, LLC since 2016.
Former jobs include President & Chief Executive Officer at Therapeutics 2000, Inc. from 1995 to 2003, Independent Non-Executive Director at Plus Therapeutics, Inc. from 2020 to 2026, President-Luna Nanoworks Division at Luna Innovations, Inc. from 2004 to 2010, President at OncoVector, Inc., and Chief Scientific Officer at MediVector, Inc. from 2010 to 2016.
Education includes undergraduate and doctorate degrees from the Massachusetts Institute of Technology.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
PLUS THERAPEUTICS, INC. 0,08 % | 2026-03-18 | 5 573 ( 0,08 % ) | 32 435 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
Houston Partners
Houston Partners Investment ManagersFinance Acts as an alternative investment manager | Företagsledare/Principal | - |
Lenk Pharmaceuticals, LLC | President | 2016-01-01 |
POP Biotechnologies, Inc.
POP Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
| PLUS THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2026-03-20 |
MediVector, Inc.
MediVector, Inc. Medical/Nursing ServicesHealth Services MediVector, Inc. is a private company based in Cambridge, MA and has subsidiaries in the United States. | Teknisk/Vetenskaplig/F&U Direktör | 2016-01-01 |
| LUNA INNOVATIONS INCORPORATED | Företagsledare/Principal | 2010-04-15 |
Therapeutics 2000, Inc. | Verkställande Direktör | 2003-09-01 |
Argus Pharmaceuticals, Inc.
Argus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Grundare | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 11 |
|---|---|
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets therapeutic products to treat cancer and related diseases | Health Technology |
Luna Innovations, Inc.
Luna Innovations, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops and distributes fiber optic test, measurement and control products | Electronic Technology |
Argus Pharmaceuticals, Inc.
Argus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Houston Partners
Houston Partners Investment ManagersFinance Acts as an alternative investment manager | Finance |
Plus Therapeutics, Inc.
Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
MediVector, Inc.
MediVector, Inc. Medical/Nursing ServicesHealth Services MediVector, Inc. is a private company based in Cambridge, MA and has subsidiaries in the United States. | Health Services |
OncoVector, Inc. | |
Therapeutics 2000, Inc. | |
Lenk Pharmaceuticals, LLC | |
POP Biotechnologies, Inc.
POP Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån